Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer.
Publication
, Conference
Berchuck, A; Henriott, A; Wenham, RM; Calingaert, B; Ali, S; Rodriguez, GC; Marks, JR; Schildkraut, JM
Published in: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
November 1, 2003
Duke Scholars
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
ISSN
1055-9965
Publication Date
November 1, 2003
Volume
12
Issue
11
Start / End Page
1340S / 1340S
Location
PHOENIX, ARIZONA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
2nd Annual AACR International Conference on Frontiers in Cancer Prevention Research
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Berchuck, A., Henriott, A., Wenham, R. M., Calingaert, B., Ali, S., Rodriguez, G. C., … Schildkraut, J. M. (2003). Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer. In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (Vol. 12, pp. 1340S-1340S). PHOENIX, ARIZONA: AMER ASSOC CANCER RESEARCH.
Berchuck, A., A. Henriott, R. M. Wenham, B. Calingaert, S. Ali, G. C. Rodriguez, J. R. Marks, and J. M. Schildkraut. “Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 12:1340S-1340S. AMER ASSOC CANCER RESEARCH, 2003.
Berchuck A, Henriott A, Wenham RM, Calingaert B, Ali S, Rodriguez GC, et al. Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer. In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2003. p. 1340S-1340S.
Berchuck, A., et al. “Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer.” CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, vol. 12, no. 11, AMER ASSOC CANCER RESEARCH, 2003, pp. 1340S-1340S.
Berchuck A, Henriott A, Wenham RM, Calingaert B, Ali S, Rodriguez GC, Marks JR, Schildkraut JM. Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2003. p. 1340S-1340S.
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
ISSN
1055-9965
Publication Date
November 1, 2003
Volume
12
Issue
11
Start / End Page
1340S / 1340S
Location
PHOENIX, ARIZONA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
2nd Annual AACR International Conference on Frontiers in Cancer Prevention Research
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences